NIH-funded research R01 grant

Immune reprogramming with bioengineered scaffolds to treat brain infection after skull surgery

Official title: Immune reprogramming with bioengineered scaffolds for the treatment of biofilm infection

Funded at University of Nebraska Medical Center · NIH-11449110 · Data updated 2026-11-12

A research grant aims to test new bioengineered scaffolds that use the immune system to fight infections that can occur after craniotomy surgeries.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Nebraska Medical Center
NIH-funded
Lab location1 site (Omaha, United States)
Project startJune 24, 2026
Project endMay 31, 2031
Funding year2026
Award (this year)$762,758
NIH project number1R01AI192682-01A1
Project IDNIH-11449110 on NIH RePORTER

Who could benefit from this research

Could help

Patients who have undergone craniotomy and are at risk for or currently dealing with post-surgical brain infections caused by biofilm-forming bacteria.

Less likely to help

Patients without craniotomy-related infections or with non-biofilm infectious conditions may not benefit from this specific approach.

What this research studies

This project uses a mouse model of Staphylococcus aureus infection after skull-opening surgery to study how 3D bioprinted antibiotic scaffolds can control and eradicate biofilm-related infections in the brain area. By combining immune-modulating approaches with locally delivered antibiotics, the work seeks to create scaffolds that release drugs directly at the surgical site. The goal is to develop a safer, more effective treatment that bypasses the delays and side effects of systemic antibiotics. Results could inform future therapies to reduce post-surgical infections in neurosurgery patients.

Why it matters

Potential benefit: If successful, patients could experience fewer post-craniotomy infections and fewer surgeries to remove or replace infected tissue.

How similar studies have gone: Previous work shows promise for localized antibiotic delivery and bioengineered scaffolds, but this exact immune-reprogramming scaffold approach is novel.

Where this research is happening

  • University of Nebraska Medical Center
    Omaha, United States
    Active

Researchers

  • Principal investigator: Kielian, Tammy L — University of Nebraska Medical Center
  • Study coordinator: Kielian, Tammy L

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.